Doctors Use CRISPR Technology to Boost Cancer Immunotherapy
THURSDAY, Nov. 10, 2022 (HealthDay News) — Gene editing has for the first time produced modified immune cells finely honed to target and attack cancer cells, researchers say.A team used the gene editing tool CRISPR to alter immune cells drawn from 16…
Learn MoreUna terapia genética ayuda a las personas con una forma rara de ceguera a ver mejor de noche
JUEVES, 13 de octubre de 2022 (HealthDay News) — Una terapia genética experimental ofrece esperanzas de una rápida mejora de la visión nocturna a los adultos que sufren de una forma congénita de ceguera de inicio en la niñez, informan unos investigad…
Learn MoreGene Therapy Helps Those With Rare Form of Blindness See Better at Night
THURSDAY, Oct. 13, 2022 (HealthDay News) — An experimental gene therapy offers hope for rapid improvement in the night vision of adults who have a congenital form of childhood-onset blindness, researchers report.In this ongoing clinical trial at the …
Learn MoreFDA Approves First Cell-Based Gene Therapy for Beta-Thalassemia
MONDAY, Aug. 22, 2022 (HealthDay News) — The U.S. Food and Drug Administration has approved Zynteglo (betibeglogene autotemcel), the first cell-based gene therapy for the treatment of adult and pediatric patients with beta-thalassemia who require r…
Learn MoreLa terapia genética logra avances contra una forma de hemofilia
VIERNES, 22 de julio de 2022 (HealthDay News) — Las personas con hemofilia B podrían experimentar una reducción dramática en su riesgo de sangrado con tan solo una inyección de una terapia genética experimental, informa un nuevo estudio. La hemofilia…
Learn MoreGene Therapy Makes Inroads Against a Form of Hemophilia
FRIDAY, July 22, 2022 (HealthDay News) — People with hemophilia B could find their bleeding risk dramatically reduced with just one injection of an experimental gene therapy, a new study reports.Hemophilia B is a rare and inherited genetic disorder i…
Learn More